We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Regeneron’s COVID-19 Antibody Appears to Help Nonhospitalized Patients
Regeneron’s COVID-19 Antibody Appears to Help Nonhospitalized Patients
Regeneron Pharmaceuticals yesterday unveiled early data on its COVID-19 antibody cocktail in which the drug appeared to provide a benefit for nonhospitalized COVID-19 patients.